Response to Letters about “Randomized Trial of a Generative AI Chatbot for Mental Health Treatment”

Michael V. Heinz; Daniel M. Mackin; Brianna M. Trudeau; Yinzhou Wang; Abigail J. Salzhauer; Tess Z Griffin; Nicholas C. Jacobson

doi:10.1056/aip2500680

August 28, 2025NEJM AI

Response to Letters about “Randomized Trial of a Generative AI Chatbot for Mental Health Treatment”

View Full Paper

Ask AI

Bookmark

Share

Key Points

The feedback emphasizes the relevance of generative AI in mental health treatments.
Expert insights suggest that the chatbot, Therabot, could have a significant impact on mental health treatment approaches.
These responses may pave the way for more elaborate studies on AI applications in therapeutic contexts.
The ongoing dialogue showcases the evolving intersection of technology and mental health care.

Implication

Responses highlight insights on generative AI chatbot Therabot's effectiveness in mental health, indicating potential benefits.

Abstract

The authors appreciate the thoughtful responses provided by Heckman et al. and Gratch and Essig regarding their recent publication evaluating the generative AI chatbot, Therabot.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Heinz et al. (2025) studied this question.

synapsesocial.com/papers/68bb3ee82b87ece8dc957113 https://doi.org/10.1056/aip2500680

View Full Paper

Ask AI

Bookmark

Share

Response to Letters about “Randomized Trial of a Generative AI Chatbot for Mental Health Treatment”

Key Points

Implication

Abstract

Discussion

Cite This Study

Response to Letters about “Randomized Trial of a Generative AI Chatbot for Mental Health Treatment”

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading